Obesity Trials Clinical Pharmacology Case Study

This case study details the execution of over 20 Phase I and Ib obesity studies conducted by Fortrea within a tight timeframe of one and a half to two years. The study outlines the challenges faced, including patient recruitment, regulatory complexity, and the need for specialized infrastructure to support the trials. Fortrea utilized its Clinical Pharmacology Services (CPS) sites and external specialists to optimize timelines while maintaining quality standards. Centralized program management was implemented to ensure consistency across studies, with regular team meetings facilitating transparent communication. The case study highlights the operational logistics of Fortrea's Clinical Research Units (CRUs) in the U.S. and UK, which are equipped to handle complex study designs and diverse patient populations. The outcomes of the program are significant, with all studies completed on time and regulatory submissions delivered flawlessly, leading to the approval and launch of two drugs for obesity and diabetes, thus improving patient outcomes globally.